Globus Medical (GMED) Liabilities and Shareholders Equity (2011 - 2026)

Globus Medical (GMED) has reported Liabilities and Shareholders Equity for 16 consecutive years, with $5.5 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 10.63% year-over-year to $5.5 billion; the trailing twelve-month figure through Jun 2026 stood at $21.3 billion (up 6.58% YoY), and the FY2025 full-year result was $5.3 billion, up 0.97% from the prior year.
• Liabilities and Shareholders Equity grew to $5.5 billion in Q2 2026 per GMED's latest filing, from $5.4 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $5.5 billion in Q2 2026 and bottomed at $1.9 billion in Q2 2022.
• Historically, Liabilities and Shareholders Equity has averaged $4.1 billion across 5 years, with a median of $5.0 billion in 2024.
• The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity jumped 170.98% in 2023, then decreased 5.04% in 2024.
• Over 5 years, Liabilities and Shareholders Equity stood at $2.1 billion in 2022, then soared by 144.98% to $5.1 billion in 2023, then grew by 3.26% to $5.3 billion in 2024, then increased by 0.97% to $5.3 billion in 2025, then gained by 3.5% to $5.5 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $5.5 billion, $5.4 billion, and $5.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.